Diastika Biotekindo Tbk. vs Kalbe Farma Tbk — how do they compare? Diastika Biotekindo Tbk. trades at Rp132 (market cap 534.73B, 418.3K 24h volume), while Kalbe Farma Tbk trades at Rp800 (market cap 37.45T, 41.79M 24h volume). The key difference: Kalbe Farma Tbk is far larger — about 70× Diastika Biotekindo Tbk.'s market cap, and Kalbe Farma Tbk is more actively traded (41.79M versus 418.3K). Which is the better fit depends on your goals.
| CHEK | KLBF | |
|---|---|---|
Market Cap | 534.73B | 37.45T |
Volume | 418.3K | 41.79M |
Lot | 4.18K | 417.89K |
Turnover | 54.5M | 33.46B |
Average Price | 130.28 | 800.79 |
Value | 54.5M | 33.46B |
Indicative Equilibrium Price | 132 | 800 |
Indicative Equilibrium Volume | 20 | 18.3K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diastika Biotekindo Tbk. (The Company) was established in Jakarta based on Deed No. 33 dated July 20, 1989 made before Mrs. Sitti Marjami Soepangat, SH. notary in Jakarta. The Company started its commercial activities in years 1986. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on CHEK →PT Kalbe Farma Tbk (the Company) was established in the Republic of Indonesia, within the framework of the Domestic Capital Investment Law No. 6 Year 1968, as amended by Law No. 12 Year 1970, basedon Notarial Deed No. 3 of Raden Imam Soesetyo Prawirokoesoemo datedon September 10th, 1966. The Company, which started commercial operation in 1966.
Read more on KLBF →